The Ottawa Hospital-Riverside Campus-The Arthritis Centre

Other News

News Update

Saphnelo™ Approved as Self-Administered Autoinjector

April 27, 2026
The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the treatment of adult patients...
News Update

Lupus & Life: Heart Health, Lupus, and How You Can Take Control

April 27, 2026
How does lupus impact heart health?  People living with systemic lupus erythematosus (SLE) face an increased risk of cardiovascular disease, with even...
News Update

FDA Accepts Application for Gazyva® (obinutuzumab) to Treat SLE

April 21, 2026
The U.S. Food and Drug Administration has accepted the supplemental Biologics License Application from Genentech for Gazyva® (obinutuzumab) to treat systemic lupus erythematosus (SLE), the most common form of...